Cargando…

Burden of paediatric respiratory syncytial virus disease and potential effect of different immunisation strategies: a modelling and cost-effectiveness analysis for England

BACKGROUND: Vaccines and prophylactic antibodies against respiratory syncytial virus (RSV) are in development and likely to be available in the next 5–10 years. The most efficient way to use these products when they become available is an important consideration for public health decision makers. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cromer, Deborah, van Hoek, Albert Jan, Newall, Anthony T, Pollard, Andrew J, Jit, Mark
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier, Ltd 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5541134/ https://www.ncbi.nlm.nih.gov/pubmed/28804787 http://dx.doi.org/10.1016/S2468-2667(17)30103-2

Ejemplares similares

Adherence to the paediatric immunisation schedule in England
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Burden and Cost of Hospitalization for Respiratory Syncytial Virus in Young Children, Singapore
por: Tam, Clarence C., et al.
Publicado: (2020)

Respiratory syncytial virus seasonality in Brazil: implications for the immunisation policy for at-risk populations
por: Freitas, André Ricardo Ribas, et al.
Publicado: (2016)

Co-administration of routine paediatric vaccines in England often deviates from the immunisation schedule
por: Bauwens, Jorgen, et al.
Publicado: (2021)

Health and economic burden of respiratory syncytial virus (RSV) disease and the cost-effectiveness of potential interventions against RSV among children under 5 years in 72 Gavi-eligible countries
por: Li, Xiao, et al.
Publicado: (2020)

Management of Respiratory Syncytial Virus Bronchiolitis: 2015 Survey of Members of the European Society for Paediatric Infectious Diseases
por: Carande, Elliott J., et al.
Publicado: (2016)

A review of the costs of delivering maternal immunisation during pregnancy
por: Procter, Simon R, et al.
Publicado: (2020)

Estimating the cost-effectiveness of maternal vaccination and monoclonal antibodies for respiratory syncytial virus in Kenya and South Africa
por: Koltai, Mihaly, et al.
Publicado: (2023)

Universal infant immunisation against respiratory syncytial virus and European inequalities: the pandemics lesson has not been learnt
por: De Luca, Daniele, et al.
Publicado: (2023)

Burden of Respiratory Syncytial Virus Hospitalizations in Canada
por: Mitchell, Ian, et al.
Publicado: (2017)

The disease burden of respiratory syncytial virus in Infants
por: Munro, Alasdair P.S., et al.
Publicado: (2023)

Maternal immunisation against Group B Streptococcus: A global analysis of health impact and cost-effectiveness
por: Procter, Simon R., et al.
Publicado: (2023)

Monitoring HPV16/18 immunisation in England and elsewhere
por: Franceschi, S
Publicado: (2010)

Reduction in HPV 16/18 prevalence in sexually active young women following the introduction of HPV immunisation in England()
por: Mesher, D., et al.
Publicado: (2013)

Monitoring the COVID-19 immunisation programme through a national immunisation Management system – England’s experience
por: Tessier, Elise, et al.
Publicado: (2023)

Cost-Effectiveness of Vaccinating Immunocompetent ≥65 Year Olds with the 13-Valent Pneumococcal Conjugate Vaccine in England
por: van Hoek, Albert Jan, et al.
Publicado: (2016)

Cost-effectiveness of pharmaceutical strategies to prevent respiratory syncytial virus disease in young children: a decision-support model for use in low-income and middle-income countries
por: Mahmud, Sarwat, et al.
Publicado: (2023)

Estimating the burden of respiratory syncytial virus (RSV) on respiratory hospital admissions in children less than five years of age in England, 2007‐2012
por: Reeves, Rachel Melanie, et al.
Publicado: (2017)

A cost-effectiveness analysis of respiratory syncytial virus (RSV) prophylaxis in infants in the United Kingdom
por: Bentley, Anthony, et al.
Publicado: (2013)

Modelled estimates of hospitalisations attributable to respiratory syncytial virus and influenza in Australia, 2009–2017
por: Nazareno, Allen L., et al.
Publicado: (2022)

Respiratory syncytial virus seasonality and prevention strategy planning for passive immunisation of infants in low-income and middle-income countries: a modelling study
por: Li, You, et al.
Publicado: (2021)

Detection of respiratory syncytial virus & Mycoplasma pneumoniae in paediatric lower respiratory tract infections
por: Kumar, Sanchit, et al.
Publicado: (2019)

Long-Term Burden and Respiratory Effects of Respiratory Syncytial Virus Hospitalization in Preterm Infants—The SPRING Study
por: Carbonell-Estrany, Xavier, et al.
Publicado: (2015)

Costs of Respiratory Syncytial Virus Hospitalizations in Colombia
por: Buendía, Jefferson Antonio, et al.
Publicado: (2020)

Developing influenza and respiratory syncytial virus activity thresholds for syndromic surveillance in England
por: Harcourt, S. E., et al.
Publicado: (2019)

Using probabilistically linked data to investigate the burden of Respiratory Syncytial Virus (RSV) in children <5 years of age on secondary care in England
por: Reeves, Rachel, et al.
Publicado: (2017)

A bibliometric analysis of systematic reviews on vaccines and immunisation
por: Fernandes, Silke, et al.
Publicado: (2018)

Transmission of paediatric respiratory syncytial virus and influenza in the wake of the COVID-19 pandemic
por: Williams, Thomas C., et al.
Publicado: (2021)

Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies
por: Newall, Anthony T., et al.
Publicado: (2010)

HPV Serology Testing Confirms High HPV Immunisation Coverage in England
por: Mesher, David, et al.
Publicado: (2016)

The age profile of respiratory syncytial virus burden in preschool children of low- and middle-income countries: A semi-parametric, meta-regression approach
por: Antillón, Marina, et al.
Publicado: (2023)

Assessment of the Effects of Active Immunisation against Respiratory Syncytial Virus (RSV) using Decision-Analytic Models: A Systematic Review with a Focus on Vaccination Strategies, Modelling Methods and Input Data
por: Treskova, Marina, et al.
Publicado: (2021)

The impact and cost-effectiveness of introducing the 10-valent pneumococcal conjugate vaccine into the paediatric immunisation programme in Iceland—A population-based time series analysis
por: Eythorsson, Elias, et al.
Publicado: (2021)

Impact and cost-effectiveness of strategies to prevent respiratory syncytial virus (RSV) disease in Vietnam: A modelling study
por: Do, Lien Anh Ha, et al.
Publicado: (2023)

Estimating the Hospital Burden of Norovirus-Associated Gastroenteritis in England and Its Opportunity Costs for Nonadmitted Patients
por: Sandmann, Frank G, et al.
Publicado: (2018)

Burden, duration and costs of hospital bed closures due to acute gastroenteritis in England per winter, 2010/11–2015/16
por: Sandmann, F.G., et al.
Publicado: (2017)

Estimates for quality of life loss due to Respiratory Syncytial Virus
por: Hodgson, David, et al.
Publicado: (2019)

Health effects of routine measles vaccination and supplementary immunisation activities in 14 high-burden countries: a Dynamic Measles Immunization Calculation Engine (DynaMICE) modelling study
por: Auzenbergs, Megan, et al.
Publicado: (2023)

Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
por: Thorrington, Dominic, et al.
Publicado: (2018)

Molecular characterization of respiratory syncytial viruses circulating in a paediatric cohort in Amman, Jordan
por: Trovão, Nídia S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5kihm0mf42jie0ks5svhe71coa